6160 · BeOne Medicines Ltd.

213.00

HKD

-4.00 (-1.843%)

08/10/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$345.31B

118.20

EV/EBITDA

53.1

DIV Yield

0%

Payout Ratio

0%

MQV Rating

2Strong

As at 08/10/2026 12:00:00 AM

Price Chart

Description

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

All-Companies
All-Consensus
HALO 100
HALO 200
HALO 50
HALO All
HALO Balance Sheet
HALO Capital Efficiency
HALO Growth
HALO Momentum
HALO Price Momentum

Key Fundamentals

EPS 3 yr Growth

-113.50%

EBITDA Margin

11.00%

Operating Cashflow

$8,791m

Free Cash Flow Return

23.10%

ROIC

5.90%

Interest Coverage

10.10

Quick Ratio

3.10

Performance

52 weeks range

Low 153 - 235.6

Trade Value (12mth)

US$25,125,077.00

1 week

-0.37%

1 month

1.97%

YTD

17.62%

1 year

10.71%

All time high

278.60

Additional Data

Shares Outstanding (Fully Diluted)

1,505m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

HKD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Strong

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Amgen, Inc.	Public Company
John V. Oyler	Individual
Xiao Dong Wang	Individual
Lai Wang	Individual
Invesco Great Wall Fund Management Co. Ltd.	Joint Venture